Literature DB >> 20001207

Targeting the TNF-alpha pathway in sarcoidosis.

Sabina A Antoniu1.   

Abstract

UNLABELLED: IMPORTANCE OF THE FIELD/SIGNIFICANCE: Sarcoidosis is a granulomatous disease with various organ manifestations in which TNF-alpha has been demonstrated to play a major pathogenic role. The existing conventional therapies are not always able to minimize TNF-alpha-driven inflammation and other approaches should be used. AREAS COVERED IN THIS REVIEW: TNF-alpha roles in sarcoid inflammation and granuloma formation are reviewed based on the literature published in the last two decades and the therapies able to target it specifically or non-specifically in sarcoidosis are discussed. WHAT THE READER WILL GAIN: A better understanding of the pathogenic role of TNF-alpha in sarcoidosis and of the scientific rationale of its therapeutic blockade. TAKE HOME MESSAGE: In some subsets of sarcoidosis with more rapid progession and/or therapeutic refractoriness TNF-alpha plays a more prominent role in disease pathogenesis, and its blockade might represent an appropriate therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20001207     DOI: 10.1517/14728220903449244

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  14 in total

Review 1.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

Review 2.  Cytokine modulators in the treatment of sarcoidosis.

Authors:  E Bargagli; C Olivieri; P Rottoli
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

3.  The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.

Authors:  Karen C Patterson; Kyle Hogarth; Aliya N Husain; Anne I Sperling; Timothy B Niewold
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

4.  Comparison of cutaneous sarcoidosis with systemic sarcoidosis: a retrospective analysis.

Authors:  Chunguang Tong; Xiuying Zhang; Jie Dong; Yanling He
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 5.  Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.

Authors:  Jean-Nicolas Boursiquot; Laurence Gérard; Marion Malphettes; Claire Fieschi; Lionel Galicier; David Boutboul; Raphael Borie; Jean-François Viallard; Pauline Soulas-Sprauel; Alice Berezne; Arnaud Jaccard; Eric Hachulla; Julien Haroche; Nicolas Schleinitz; Laurent Têtu; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2012-09-18       Impact factor: 8.317

6.  A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis.

Authors:  Gönen Mengi; Feride Göğüş
Journal:  Arch Rheumatol       Date:  2017-02-12       Impact factor: 1.472

7.  Cutaneous Conundrums in Cardiac Sarcoidosis: A Series on Skin Disease in Immunosuppression.

Authors:  Daisy Young; Sri Harsha Kanuri; Krishna Akella; Ghulam Murtaza; Rakesh Gopinathannair; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2020-08-31

8.  Disfiguring annular sarcoidosis improved by adalimumab.

Authors:  C A Kaiser; A Cozzio; G F L Hofbauer; J Kamarashev; L E French; A A Navarini
Journal:  Case Rep Dermatol       Date:  2011-05-17

9.  No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis.

Authors:  Christopher Banse; Aurélia Bisson-Vaivre; Marie Kozyreff-Meurice; Olivier Vittecoq; Vincent Goëb
Journal:  Int J Gen Med       Date:  2013-07-22

10.  PAR-2, IL-4R, TGF-β and TNF-α in bronchoalveolar lavage distinguishes extrinsic allergic alveolitis from sarcoidosis.

Authors:  Radoslav Matěj; Magdalena Smětáková; Martina Vašáková; Jana Nováková; Martina Sterclová; Jaromír Kukal; Tomáš Olejár
Journal:  Exp Ther Med       Date:  2014-06-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.